EGFR-mutant lung adenocarcinoma was regarded as a cancer type with “immune-cold” and “immunosuppressive” properties; this is important to consider in the pursuit to unveil insights into tumor immune microenvironment in EGFR-mutant lung adenocarcinoma [9,10]. This evidence concerns the gene EGFR and lung adenocarcinoma.